{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T21:21:56Z","timestamp":1751318516841},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A regional skin cancer prevention program in Eastern Finland revealed a relatively high age-standardized mortality due to malignant melanoma during 2013\u20132017. An explanation for this is needed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To analyse the 543 melanoma samples in 524 subjects collected during 2000\u20132013 at Kuopio University Hospital and reposited in the Biobank of Eastern Finland. A focus was directed to factors related to metastasis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The samples were analysed anonymously by examining the histopathological report, referral text and the list of diagnoses. A possible state of immunosuppression was evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The mean age at the diagnosis of malignant melanoma (MM), lentigo maligna (LM) and melanoma in situ was relatively high, i.e., 66.2, 72.1 and 63.3, respectively. Especially the MM type increased markedly during 2000\u20132013. In further analyses of a representative cohort of 337 samples, the proportion of nodular melanoma and LM\/LMM melanoma was relatively high, 35.6 and 22.0%, respectively, but that from superficial spreading melanoma relatively low (33.8%). Metastasis correlated with immunosuppression, male gender, Clark level, Breslow thickness, ulceration, mitosis count, invasion into vessels and\/or perineural area, microsatellites, melanoma subtype, body site, recidivism, and the absence of dysplastic nevus cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The marked increase in aggressive melanomas with associated metastasis, and the relatively high age at diagnosis, can partially explain the mortality.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08879-1","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:02:42Z","timestamp":1635465762000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types"],"prefix":"10.1186","volume":"21","author":[{"given":"Ville","family":"Suhonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaana","family":"Rummukainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Siiskonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arto","family":"Mannermaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka T.","family":"Harvima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"issue":"5","key":"8879_CR1","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","volume":"166","author":"A Lomas","year":"2012","unstructured":"Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069\u201380. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10830.x.","journal-title":"Br J Dermatol"},{"issue":"10151","key":"8879_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, et al. Melanoma. Lancet. 2018;392(10151):971\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(18)31559-9.","journal-title":"Lancet"},{"issue":"2","key":"8879_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ijc.27616","volume":"132","author":"F Erdmann","year":"2013","unstructured":"Erdmann F, Lortet-Tieulent J, Sch\u00fcz J, Zeeb H, Greinert R, Breitbart EW, et al. International trends in the incidence of malignant melanoma 1953\u20132008 \u2013 are recent generations at higher or lower risk? Int J Cancer. 2013;132(2):385\u2013400. https:\/\/doi.org\/10.1002\/ijc.27616.","journal-title":"Int J Cancer"},{"issue":"suppl 6","key":"8879_CR4","doi-asserted-by":"publisher","first-page":"vi1","DOI":"10.1093\/annonc\/mdp252","volume":"20","author":"RM MacKie","year":"2009","unstructured":"MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol. 2009;20(suppl 6):vi1\u20137.","journal-title":"Ann Oncol"},{"issue":"1","key":"8879_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.suc.2019.09.004","volume":"100","author":"A Chopra","year":"2020","unstructured":"Chopra A, Sharma R, Rao UNM. Pathology of melanoma. Surg Clin North Am. 2020;100(1):43\u201359. https:\/\/doi.org\/10.1016\/j.suc.2019.09.004.","journal-title":"Surg Clin North Am"},{"key":"8879_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejca.2017.11.023","volume":"91","author":"JJ Grob","year":"2018","unstructured":"Grob JJ, Schadendorf D, Lorigan P, Ascierto P, Larkin J, Nathan P, et al. Eighth American joint committee on Cancer (AJCC) melanoma classification: let us reconsider stage III. Eur J Cancer. 2018;91:168\u201370. https:\/\/doi.org\/10.1016\/j.ejca.2017.11.023.","journal-title":"Eur J Cancer"},{"issue":"5-6","key":"8879_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10585-018-9892-z","volume":"35","author":"JS Ankeny","year":"2018","unstructured":"Ankeny JS, Labadie B, Luke J, Hsueh E, Messina J, Zager JS. Review of diagnostic, prognostic, and predictive biomarkers in melanoma. Clin Exp Metastasis. 2018;35(5-6):487\u201393. https:\/\/doi.org\/10.1007\/s10585-018-9892-z.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"8879_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12967-017-1310-9","volume":"15","author":"J Galon","year":"2017","unstructured":"Galon J, Lugli A, Bifulco C, Pages F, Masucci G, Marincola FM, et al. World-wide Immunoscore task force: meeting report from the \"melanoma bridge\", Napoli, November 30th\u2013December 3rd, 2016. J Transl Med. 2017;15(1):212. https:\/\/doi.org\/10.1186\/s12967-017-1310-9.","journal-title":"J Transl Med"},{"issue":"5-6","key":"8879_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10585-018-9893-y","volume":"35","author":"N Turner","year":"2018","unstructured":"Turner N, Ware O, Bosenberg M. Genetics of metastasis: melanoma and other cancers. Clin Exp Metastasis. 2018;35(5-6):379\u201391. https:\/\/doi.org\/10.1007\/s10585-018-9893-y.","journal-title":"Clin Exp Metastasis"},{"issue":"7","key":"8879_CR10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrc.2017.43","volume":"17","author":"R Ossio","year":"2017","unstructured":"Ossio R, Rold\u00e1n-Mar\u00edn R, Mart\u00ednez-Said H, Adams DJ, Robles-Espinoza CD. Melanoma: a global perspective. Nature Rev Cancer. 2017;17(7):393\u20134. https:\/\/doi.org\/10.1038\/nrc.2017.43.","journal-title":"Nature Rev Cancer"},{"key":"8879_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2147\/CLEP.S151246","volume":"10","author":"TE Robsahm","year":"2018","unstructured":"Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SM, Akslen L, et al. High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry. Clin Epidemiol. 2018;10:537\u201348. https:\/\/doi.org\/10.2147\/CLEP.S151246.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"8879_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/bjc.1988.225","volume":"58","author":"A Osterlind","year":"1988","unstructured":"Osterlind A, Hou-Jensen K, M\u00f8ller JO. Incidence of cutaneous malignant melanoma in Denmark 1978\u20131982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer. 1988;58(3):385\u201391. https:\/\/doi.org\/10.1038\/bjc.1988.225.","journal-title":"Br J Cancer"},{"issue":"2","key":"8879_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/CMR.0000000000000312","volume":"27","author":"R Minini","year":"2017","unstructured":"Minini R, Rohrmann S, Braun R, Korol D, Dehler S. Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the canton of Zurich, Switzerland. Melanoma Res. 2017;27(2):145\u201351. https:\/\/doi.org\/10.1097\/CMR.0000000000000312.","journal-title":"Melanoma Res"},{"issue":"3","key":"8879_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.hoc.2009.03.013","volume":"23","author":"DL McDivitt","year":"2009","unstructured":"McDivitt DL. The classification of cutaneous melanoma. Hematol Oncol Clin North Am. 2009;23(3):501\u201313. https:\/\/doi.org\/10.1016\/j.hoc.2009.03.013.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"S2","key":"8879_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/modpathol.3800508","volume":"19","author":"BR Smoller","year":"2006","unstructured":"Smoller BR. Histologic criteria for diagnosing primary cutaneous malignant melanoma. Mod Pathol. 2006;19(S2):34\u201340. https:\/\/doi.org\/10.1038\/modpathol.3800508.","journal-title":"Mod Pathol"},{"key":"8879_CR16","doi-asserted-by":"publisher","unstructured":"Lindholm C, Andersson R, Dufmats M, Hansson J, Ingvar C, M\u00f6ller T, Sj\u00f6din H, Stierner U, Wagenius G, for the Swedish Melanoma Study Group Swedish Melanoma Study Group. Invasive cutaneous malignant melanoma in Sweden, 1990\u20131999. A prospective, population-based study of survival and prognostic factors. Cancer 2004;101:2067\u20132078, Invasive cutaneous malignant melanoma in Sweden, 1990-1999, 9, DOI: https:\/\/doi.org\/10.1002\/cncr.20602.","DOI":"10.1002\/cncr.20602"},{"issue":"10","key":"8879_CR17","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/jamadermatol.2015.1481","volume":"151","author":"NM Helvind","year":"2015","unstructured":"Helvind NM, H\u00f6lmich LR, Smith S, Glud M, Andersen KK, Dalton SO, et al. Incidence of in situ and invasive melanoma in Denmark from 1985 through 2012: a national database study of 24 059 melanoma cases. JAMA Dermatol. 2015;151(10):1087\u201395. https:\/\/doi.org\/10.1001\/jamadermatol.2015.1481.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"8879_CR18","first-page":"1005","volume":"28","author":"M Rastrelli","year":"2014","unstructured":"Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28(6):1005\u201311.","journal-title":"In Vivo"},{"issue":"1","key":"8879_CR19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12885-016-2747-6","volume":"16","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao Y, Ma S. Racial differences in six major subtypes of melanoma: descriptive epidemiology. BMC Cancer. 2016;16(1):691. https:\/\/doi.org\/10.1186\/s12885-016-2747-6.","journal-title":"BMC Cancer"},{"issue":"7","key":"8879_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.2340\/00015555-2944","volume":"98","author":"S Ribero","year":"2018","unstructured":"Ribero S, Stucci LS, Marra E, Marconcini R, Spagnolo F, Orgiano L, et al. Effect of age on melanoma risk, prognosis and treatment response. Acta Derm Venereol. 2018;98(7):624\u20139. https:\/\/doi.org\/10.2340\/00015555-2944.","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"8879_CR21","doi-asserted-by":"publisher","first-page":"75(8)","DOI":"10.1111\/all.14273","volume":"75","author":"I Fritz","year":"2020","unstructured":"Fritz I, Wagner P, Bottai M, Eriksson H, Ingvar C, Krakowski I, et al. Desloratadine and loratadine use associated with improved melanoma survival. Allergy. 2020;75(8):75(8)\u20132099. https:\/\/doi.org\/10.1111\/all.14273.","journal-title":"Allergy"},{"issue":"2","key":"8879_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jphotobiol.2010.04.002","volume":"101","author":"E Cicarma","year":"2010","unstructured":"Cicarma E, Juzeniene A, Porojnicu AC, Bruland \u00d8S, Moan J. Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966\u20132007. J Photochem Photobiol, B: Biology. 2010;101(2):174\u20138. https:\/\/doi.org\/10.1016\/j.jphotobiol.2010.04.002.","journal-title":"J Photochem Photobiol, B: Biology"},{"issue":"1","key":"8879_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/ijc.2910470104","volume":"47","author":"K Magnus","year":"1991","unstructured":"Magnus K. The nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer. Int J Cancer. 1991;47(1):12\u20139. https:\/\/doi.org\/10.1002\/ijc.2910470104.","journal-title":"Int J Cancer"},{"issue":"2","key":"8879_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/ijc.21836","volume":"119","author":"A Stang","year":"2006","unstructured":"Stang A, Pukkala E, Sankila R, S\u00f6derman B, Hakulinen T. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int J Cancer. 2006;119(2):380\u20134. https:\/\/doi.org\/10.1002\/ijc.21836.","journal-title":"Int J Cancer"},{"issue":"4","key":"8879_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1365-2133.2007.08429.x","volume":"158","author":"B Perez-Gomez","year":"2008","unstructured":"Perez-Gomez B, Aragones N, Gustavsson P, et al. Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women. Br J Dermatol. 2008;158(4):766\u201372. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08429.x.","journal-title":"Br J Dermatol"},{"issue":"9","key":"8879_CR26","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1245\/s10434-013-2977-7","volume":"20","author":"N Fadaki","year":"2013","unstructured":"Fadaki N, Li R, Parrett B, Sanders G, Thummala S, Martineau L, et al. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome? Ann Surg Oncol. 2013;20(9):3089\u201397. https:\/\/doi.org\/10.1245\/s10434-013-2977-7.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"8879_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/DAD.0000000000000265","volume":"37","author":"I Pastushenko","year":"2015","unstructured":"Pastushenko I, Vicente-Arregui S, Van den Eynden GG, et al. Melanomas arising on skin with chronic sun-induced damage exhibit low degree of angiogenesis and lymphangiogenesis. Am J Dermatopathol. 2015;37(6):451\u20134. https:\/\/doi.org\/10.1097\/DAD.0000000000000265.","journal-title":"Am J Dermatopathol"},{"key":"8879_CR28","doi-asserted-by":"publisher","unstructured":"Smalley KS. Why do women with melanoma do better than men? eLife. 2018;7. https:\/\/doi.org\/10.7554\/eLife.33511.","DOI":"10.7554\/eLife.33511"},{"issue":"10","key":"8879_CR29","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1002\/1097-0142(19950515)75:10<2492::AID-CNCR2820751015>3.0.CO;2-W","volume":"75","author":"C Garbe","year":"1995","unstructured":"Garbe C, B\u00fcttner P, Bertz J, Burg G, D'Hoedt B, Drepper H, et al. Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer. 1995;75(10):2492\u20138. https:\/\/doi.org\/10.1002\/1097-0142(19950515)75:10<2492::AID-CNCR2820751015>3.0.CO;2-W.","journal-title":"Cancer"},{"issue":"7","key":"8879_CR30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/archdermatol.2011.159","volume":"147","author":"JD Brewer","year":"2011","unstructured":"Brewer JD, Christenson LJ, Weaver AL, Dapprich DC, Weenig RH, Lim KK, et al. Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol. 2011;147(7):790\u20136. https:\/\/doi.org\/10.1001\/archdermatol.2011.159.","journal-title":"Arch Dermatol"},{"issue":"11","key":"8879_CR31","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/jid.2015.312","volume":"135","author":"HA Robbins","year":"2015","unstructured":"Robbins HA, Clarke CA, Arron ST, Tatalovich Z, Kahn AR, Hernandez BY, et al. Melanoma risk and survival among organ transplant recipients. J Invest Dermatol. 2015;135(11):2657\u201365. https:\/\/doi.org\/10.1038\/jid.2015.312.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"8879_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/CMR.0b013e32833e9f5b","volume":"20","author":"A Frankenthaler","year":"2010","unstructured":"Frankenthaler A, Sullivan RJ, Wang W, Renzi S, Seery V, Lee MY, et al. Impact of concomitant immunosuppression on the presentation and prognosis of patients with melanoma. Melanoma Res. 2010;20(6):496\u2013500. https:\/\/doi.org\/10.1097\/CMR.0b013e32833e9f5b.","journal-title":"Melanoma Res"},{"issue":"3","key":"8879_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jaad.2015.06.052","volume":"73","author":"T Donahue","year":"2015","unstructured":"Donahue T, Lee CY, Sanghvi A, Obregon R, Sidiropoulos M, Cooper C, et al. Immunosuppression is an independent prognostic factor associated with aggressive tumor behavior in cutaneous melanoma. J Am Acad Dermatol. 2015;73(3):461\u20136. https:\/\/doi.org\/10.1016\/j.jaad.2015.06.052.","journal-title":"J Am Acad Dermatol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08879-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08879-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08879-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:03:15Z","timestamp":1635465795000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08879-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8879"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08879-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"National Supervisory Authority for Welfare and Health (Valvira) and the Ethics Committee of research at Kuopio University Hospital have given the authorization to transfer the samples and related information from Kuopio University Hospital to the Biobank of Eastern Finland. The research plan was approved by the scientific committee of the Biobank of Eastern Finland. The samples and patients in this study were analysed anonymously without an access to detailed medical records. The legal permission to use biobank material for research is based on the national Biobank Law and therefore a consent was neither required nor obtained from the study subjects. All the experiment protocol for involving human data. i.e., material reposited and stored in the biobank, was in accordance with the national Biobank Law.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"(not applicable)","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1155"}}